首站-论文投稿智能助手
典型文献
A type Ⅲ-E CRISPR Craspase exhibiting RNase and protease activities
文献摘要:
Type Ⅲ-E CRISPR-Cas effector gRAMP/Cas7-11 is a RNA-guided RNA endonuclease associated with a putative caspase-like protease TRP-CHAT/Csx29,which targets endogenous protein substrate Csx30.In a recent paper published in Science,the Ailong Ke lab has captured cryo-EM snapshots of the nuclease-protease complex Craspase in both resting and different functional states;this paper together with four other related studies have elucidated the molecular mechanisms of both target RNA cleavage and RNA-mediated allosteric regulation of protease catalytic activity,thereby highlighting RNA-dependent protease-based programmed cell death.
文献关键词:
作者姓名:
Hui Yang;Dinshaw J.Patel
作者机构:
State Key Laboratory of Molecular Biology,Shanghai Institute of Biochemistry and Cell Biology,Center for Excellence in Molecular Cell Science,Chinese Academy of Sciences,University of Chinese Academy of Sciences,Shanghai,China;Structural Biology Program,Memorial Sloan-Kettering Cancer Center,New York,NY,USA
引用格式:
[1]Hui Yang;Dinshaw J.Patel-.A type Ⅲ-E CRISPR Craspase exhibiting RNase and protease activities)[J].细胞研究(英文版),2022(12):1044-1046
A类:
Craspase,gRAMP,Cas7,Csx29,Csx30,Ailong
B类:
type,CRISPR,exhibiting,RNase,protease,activities,Type,effector,guided,endonuclease,associated,putative,caspase,like,TRP,CHAT,which,targets,endogenous,protein,substrate,In,recent,paper,published,Ke,lab,has,captured,cryo,EM,snapshots,complex,both,resting,different,functional,states,this,together,four,other,related,studies,have,elucidated,molecular,mechanisms,cleavage,mediated,allosteric,regulation,catalytic,activity,thereby,highlighting,dependent,programmed,cell,death
AB值:
0.630559
相似文献
Parthenolide reveals an allosteric mode to inhibit the delSGylation activity of SARS-CoV-2 papain-like protease
Zhihui Zou;Huizhuang Shan;Demeng Sun;Li Xia;Yulong Shi;Jiahui Wan;Aiwu Zhou;Yunzhao Wu;Hanzhang Xu;Hu Lei;Zhijian Xu;Yingli Wu-Hongqiao International Institute of Medicine,Shanghai Tongren Hospital/Faculty of Basic Medicine,Chemical Biology Division of Shanghai Universities E-Institutes,Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education,Chinese Academy of Medical Sciences Research Unit 2019RU043,Shanghai Jiao Tong University School of Medicine(SJTU-SM),Shanghai 200025,China;Laboratory Medicine,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,Guangdong 510000,China;Tsinghua-Peking Center for Life Sciences,Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology(Ministry of Education),Beijing Advanced Innovation Center for Structural Biology,Department of Chemistry,Tsinghua University,Beijing 100084,China;CAS Key Laboratory of Receptor Research,Drug Discovery and Design Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
Identification of sitagliptin binding proteins by affinity purification mass spectrometry
Xue-Ning Wang;Byu-Ri Sim;Hong Chen;Yun-Xiao Zheng;Jun-Biao Xue;Lei Wang;Wei-Sha Kong;Kuan Zhou;Shu-Juan Guo;Jing-Li Hou;Jiong Zhang;He-Wei Jiang;Sheng-Ce Tao-Shanghai Center for Systems Biomedicine,Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Jiao Tong University,Shanghai 200240,China;State Key Laboratory of Microbial Metabolism,Joint International Research Laboratory of Metabolic and Developmental Sciences,MOE-LSB&MOE-LSC,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;Instrumental Analysis Center,Shanghai Jiao Tong University,Shanghai 200240,China,41nflammation and Immune Mediated Diseases Laboratory of Anhui Province,School of Pharmacy,Anhui Medical University,Hefei 230032,China;Key Laboratory of Organofluorine Chemistry,Center for Excellence in Molecular Synthesis,Shanghai Institute of Organic Chemistry,University of the Chinese Academy of Sciences,Chinese Academy of Sciences,Shanghai 200032,China.
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。